{"nct_id":"NCT04626297","title":"A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)","status":"COMPLETED","status_verified_date":"2023-10","start_date":"2020-11-17","start_date_type":"ACTUAL","primary_completion_date":"2022-08-03","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}